Julia Delahousse
2PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|May 03, 2024
Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors.Laurent Mathiot, David Combarel, Justin Cagnat
|Aug 14, 2020
Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects.Julia Delahousse, Charles Skarbek, Mélanie Desbois
Pageof 1
